- Home
- JAKK vs BDTX Comparison
JAKK vs BDTX Comparison
Compare JAKK & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- BDTX
- Stock Information
- Founded
- JAKK 1995
- BDTX 2014
- Country
- JAKK United States
- BDTX United States
- Employees
- JAKK N/A
- BDTX N/A
- Industry
- JAKK Recreational Games/Products/Toys
- BDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JAKK Consumer Discretionary
- BDTX Health Care
- Exchange
- JAKK Nasdaq
- BDTX Nasdaq
- Market Cap
- JAKK 206.8M
- BDTX 220.3M
- IPO Year
- JAKK 1996
- BDTX 2020
- Fundamental
- Price
- JAKK $16.81
- BDTX $3.62
- Analyst Decision
- JAKK Strong Buy
- BDTX Strong Buy
- Analyst Count
- JAKK 3
- BDTX 5
- Target Price
- JAKK $36.67
- BDTX $10.40
- AVG Volume (30 Days)
- JAKK 110.2K
- BDTX 795.1K
- Earning Date
- JAKK 10-30-2025
- BDTX 11-05-2025
- Dividend Yield
- JAKK 5.96%
- BDTX N/A
- EPS Growth
- JAKK N/A
- BDTX N/A
- EPS
- JAKK 0.53
- BDTX 0.25
- Revenue
- JAKK $574,298,000.00
- BDTX $70,000,000.00
- Revenue This Year
- JAKK N/A
- BDTX N/A
- Revenue Next Year
- JAKK $4.06
- BDTX N/A
- P/E Ratio
- JAKK $31.65
- BDTX $14.46
- Revenue Growth
- JAKK N/A
- BDTX N/A
- 52 Week Low
- JAKK $15.50
- BDTX $1.20
- 52 Week High
- JAKK $35.79
- BDTX $4.45
- Technical
- Relative Strength Index (RSI)
- JAKK 34.01
- BDTX 44.71
- Support Level
- JAKK $15.51
- BDTX $3.71
- Resistance Level
- JAKK $17.05
- BDTX $3.97
- Average True Range (ATR)
- JAKK 0.70
- BDTX 0.23
- MACD
- JAKK -0.31
- BDTX -0.06
- Stochastic Oscillator
- JAKK 29.42
- BDTX 0.00
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About BDTX Black Diamond Therapeutics Inc.
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.